XML 94 R81.htm IDEA: XBRL DOCUMENT v3.25.1
Deferred Policy Acquisition Costs, Deferred Reinsurance Losses, Deferred Reinsurance Gains And Deferred Sales Inducements (Balance of and Changes in DAC) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]      
Deferred Policy Acquisition Cost, Beginning Balance $ 7,144,736 [1] $ 6,956,197 $ 7,029,308
Capitalization 1,533,858 1,121,435 989,342
Amortization Expense (603,357) (539,510) (521,269)
Other (268,177) (393,386) (541,184)
Balance, end of period 7,807,060 7,144,736 [1] 6,956,197
Fixed Annuities      
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]      
Deferred Policy Acquisition Cost, Beginning Balance 197,937 102,251 84,481
Capitalization 216,410 117,851 31,494
Amortization Expense (42,705) (22,165) (13,724)
Other 0 0 0
Balance, end of period 371,642 197,937 102,251
Variable Annuties      
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]      
Deferred Policy Acquisition Cost, Beginning Balance 3,298,935 3,759,819 3,806,732
Capitalization 430,520 263,869 296,597
Amortization Expense (356,254) (331,368) (343,510)
Other 0 (393,385) 0
Balance, end of period 3,373,201 3,298,935 3,759,819
Term Life      
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]      
Deferred Policy Acquisition Cost, Beginning Balance 743,888 648,837 577,084
Capitalization 183,463 159,000 127,541
Amortization Expense (63,447) (63,949) (55,423)
Other (249,836) 0 (365)
Balance, end of period 614,068 743,888 648,837
Variable / Universal Life      
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]      
Deferred Policy Acquisition Cost, Beginning Balance 2,903,976 2,445,290 2,561,011
Capitalization 703,465 580,715 533,710
Amortization Expense (140,951) (122,028) (108,612)
Other (18,341) (1) (540,819)
Balance, end of period $ 3,448,149 $ 2,903,976 $ 2,445,290
[1] Amounts reflect revision to prior period Financial Statements. See Note 17 for additional information.